Skip to main content
Caplight Logo









NeoCura Bio-Medical Technology Co., Ltd.

NeoCura Bio-Medical Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.neocura.com.cn/

Last Round

Series A

Extension

Dec 21, 2021

Total Funding Raised

$116.65M

Company Overview

NeoCura Bio-Medical Technology Co., Ltd. is a biotechnology company that develops an artificial intelligence-driven RNA technology platform for the research and development of innovative tumor vaccines and immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

mRNA vaccineneoantigen vaccineAI drug discoveryRNA therapeuticsprecision medicinemulti-omicsbioinformaticscancer immunotherapydrug design platformsolid tumor treatmentin silico drug discoveryAI biotechpersonalized medicinecomputational biologybiopharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeoCura Bio-Medical Technology Co., Ltd. Comparables

Compare NeoCura Bio-Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

NeoCura Bio-Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Likang Life Sciences
85%
myNEO Therapeutics
83%
Evaxion A/S
79%

NeoCura Bio-Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 21, 2021
Series ADec 24, 2020

NeoCura Bio-Medical Technology Co., Ltd. Investors

Notable investors and investment history

NeoCura Bio-Medical Technology Co., Ltd. investors
InvestorRounds
Alwin CapitalSeries A
IDG CapitalSeries A
PICC Capital Insurance Asset ManagementSeries A Extension
Kunlun CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Added Lastoria, a medical devices startup, as a customer.

  • Dec 21, 2021

    $78M round led by PICC Capital and Zhou Yahui.

NeoCura Bio-Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeoCura Bio-Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeoCura Bio-Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range8
Year Founded2017
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?